SCHEMBL20005005

SCHEMBL20005005

C=C(/C=C\C(=C/C)N1CCC(c2ccccc2)CC1)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.48
▸ KCNH2 Q12809 1/20 0.48
▸ MAPT P10636 3/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ SLC18A3 Q16572 2/20 0.41
▸ LIPE Q05469 2/20 0.40
▸ ADAMTS5 Q9UNA0 2/20 0.40
▸ PRCP P42785 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22300290 0.78 HRH3 (0.56) HRH3KCNH2NPC1RAB9ASMN1; SMN2
SCHEMBL27675727 0.73 KCNH2 (0.53) HRH3KCNH2MAPTNPC1RAB9A
SCHEMBL13588778 0.72 KCNH2 (0.64) HRH3KCNH2NPC1RAB9ASMN1; SMN2
SCHEMBL22537843 0.70 HRH3 (0.55) HRH3KCNH2MAPTNPC1RAB9A
SCHEMBL19139666 0.70 KCNH2 (0.42) HRH3KCNH2MAPTNPC1RAB9A
SCHEMBL20331351 0.70 ALDH1A1 (0.44) MAPTNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL13182918 0.70 NPC1 (0.59) HRH3KCNH2MAPTNPC1RAB9A
SCHEMBL13588795 0.70 HRH3 (0.61) HRH3KCNH2NPC1RAB9ASMN1; SMN2
SCHEMBL19703077 0.69 ADAMTS5 (0.57) HRH3KCNH2SMN1; SMN2LIPEADAMTS5
SCHEMBL4053721 0.67 DRD2 (0.55) SMN1; SMN2SLC18A3DRD2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515912-B1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NAT RECH SCIENT (FR) 2020-10-14 — — EP disclosed
WO-2018055316-A1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-29 — — WO disclosed
Send feedback